Abstract
1. Recent publication has suggested that quinacrine may be a candidate for treatment of Creutzfeldt-Jakob disease (CJD). But serious toxicity of quinacrine to liver and hematological system has been reported.
2. We disclosed the permeability of quinacrine can be enhanced by presence of p-glycoprotein inhibitor at blood–brain barrier in vitro. Therefore, we tried the protocol of combination of quinacrine and p-glycoprotein inhibitor, verapamil for patients with CJD.
3. When compared clinical effects by quinacrine and the combination therapy, improvement of clinical findings was observed at the same level without any adverse effects. Low-dose quinacrine with verapamil can be used as safe treatment of CJD.
Keywords: quinacrine, sporadic Creutzfeldt-Jakob disease, p-glycoprotein inhibitor
References
- Doh-ura, K., Mekada, E., Ogomori, K., and Iwaki, T. (2000). Enhanced CD9 expression in the mouse and human brains infected with transmissible spongiform encephalopathies. J. Neuropathol. Exp. Neurol.59(9):774–785 [DOI] [PubMed] [Google Scholar]
- Korth, C., May, B. C., Cohen, F. E., and Prusiner, S. B. (2001). Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease. Proc. Natl. Acad. Sci.98(17):9836–9841 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Scoazec, J. Y., Krolak-Salmon, P., Casez, O., Besson, G., Thobois, S., Kopp, N., et al. (2003). Quinacrine-induced cytolytic hepatitis in sporadic Creutzfeldt-Jakob disease. Ann. Neurol.53(4):546–547 [DOI] [PubMed] [Google Scholar]
- Dohgu, S., Yamauchi, A., Takata, F., Sawada, Y., Higuchi, S., Naito, M., Tsuruo, T., Shirabe, S., Niwa, M., Katamine, S., and Kataoka, Y. (2003). Uptake and Efflux of Quinacrine, a Candidate for the Treatment of Prion Diseases at the Blood-Brain Barrier. Cell Mol. Neurobiol. (in press) [DOI] [PMC free article] [PubMed]
- Björkman, S., and Elisson, L. O. (1987). Determination of quinacrine (mepacrine) in plasma by high-performance liquid chromatography with fluorimetric detection. J Chromatograph420:341–348 [DOI] [PubMed] [Google Scholar]